| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 08/24/2005 | CN1215871C Medicinal tea for treating alopecia areata, seborrheic alpoecia and nervoalopecia |
| 08/24/2005 | CN1215864C Medicament for treating burn and scald |
| 08/24/2005 | CN1215859C Tincture for treating vitiligo and its prepn method |
| 08/24/2005 | CN1215855C Externally applied medicine for stopping itching, relieving pain and eliminating swelling |
| 08/24/2005 | CN1215763C Alcohol-containing anti-microbial compositions with cosmetic apparatus |
| 08/23/2005 | US6933321 For therapy of androgen-dependent diseases such as prostate cancer, benign prostatic hyperplasia, precicious puberty, polycystic ovarian syndrome, acne, hirsutism, seborrhea, androgenic alopecia and premature male baldness |
| 08/23/2005 | US6933314 Integrin receptor inhibitors |
| 08/23/2005 | US6933306 Anticancer agents; antiinflammatory agents; autoimmune disease |
| 08/23/2005 | US6933303 Antidiabetic agents |
| 08/23/2005 | US6933296 A 2H-pyridazine-1-one derivatives as bronchodilator agents for the treatment of asthma, chronic obstructive pulmonary disease, respiratory system disorders |
| 08/23/2005 | US6933279 Peptides comprising a class A amphipathic helix when formulated with "D" amino acid residue(s) and/or having protected amino and carboxyl termini |
| 08/23/2005 | US6933129 Method for culturing and assaying cells |
| 08/23/2005 | US6933113 Modulation of endogenous gene expression in cells |
| 08/23/2005 | US6932984 Method of microencapsulation |
| 08/23/2005 | US6932973 Peptides which stimulate the expression of the cytokines of inflammation and promote tissue regeneration |
| 08/23/2005 | US6932969 Ig fractions having immunomodulatory activity |
| 08/23/2005 | US6932963 Treatment of skin wounds using polyenylphosphatidylcholine and alkanolamines |
| 08/23/2005 | CA2267661C Variants of vascular endothelial cell growth factor having antagonistic properties |
| 08/23/2005 | CA2153235C Compounds having selectivity for retinoid x receptors |
| 08/23/2005 | CA2147341C Skin treatment composition comprising l-lactic acid and n-acetyl-l-cysteine |
| 08/18/2005 | WO2005074987A1 Photodynamic therapy for the treatment of acne |
| 08/18/2005 | WO2005074968A2 Medical use of basic peptides |
| 08/18/2005 | WO2005074955A1 Preparations containing echinacea extracts and thiocyanate |
| 08/18/2005 | WO2005074911A1 Protein kinase c activator |
| 08/18/2005 | WO2003004608A3 Drug metabolizing enzymes |
| 08/18/2005 | US20050182244 Modified polypeptides stabilized in a desired conformation and methods for producing same |
| 08/18/2005 | US20050182142 1,2-alkanediol, and citral, geraniol, nerol, perillaldehyde, alpha -terpineol, dodecanol and/or L-carvone |
| 08/18/2005 | US20050182129 Hair growth tonic |
| 08/18/2005 | US20050182094 N-[[4-(2-Chloro-4-fluorophenoxy)[1,4'-bipiperidin]-1'-yl]carbonyl]-4-methyl benzenesulfonamide, used for prophylaxis of respiratory system disorders or as antiallergens |
| 08/18/2005 | US20050182093 Novel compounds |
| 08/18/2005 | US20050182057 Aryl N-cyanoguanidines and methods related thereto |
| 08/18/2005 | US20050182042 Pharmaceutical composition comprising a renin inhibitor, a calcium channel blocker and a diuretic |
| 08/18/2005 | US20050182035 cyclohexane ring is 3,5-dihydroxy-substituted and 2,4-alkylene-bridged; treating metabolic bone disease, cancer, skin disorders, immune system disorders, asthma, hypertension, hypothyroidism, hypocalcemia, female infertility and alopecia |
| 08/18/2005 | US20050182034 Method of locking 1alpha-OH of vitamin D compounds in axial orientation |
| 08/18/2005 | US20050182017 Immunostimulatory nucleic acid molecules |
| 08/18/2005 | US20050182003 Drugs to be used in gene therapy for recessively transmitted genetic disease |
| 08/18/2005 | US20050181999 Comprising a biologically active agent (e.g., antifungal) , urea and an acid (lactic acid) or ethoxydiglycol; provide better bioavailability of the active agent within the nail |
| 08/18/2005 | US20050181996 Stimulation of cartilage growth with agonists of the non-proteolytically activated thrombin receptor |
| 08/18/2005 | US20050181995 Venom-derived vascular endothelial growth factor-like protein having binding activity specific to vascular endothelial growth factor receptor type 2 and use thereof |
| 08/18/2005 | US20050181972 Modification of the properties of a fibrin matrix with respect to growth and ingrowth of cells |
| 08/18/2005 | US20050181457 Mixture comprising immunogllobulin G complex for diagnosis, prevention and treatment of autoimmune and allergic disorders |
| 08/18/2005 | US20050181448 Biological products |
| 08/18/2005 | US20050181391 Method of detecting and treating tuberous sclerosis complex associated disorders |
| 08/18/2005 | US20050181362 Aligning the test nuclear receptor (NR) polypeptide, with at least one reference NR polypeptide sequence for which an X-ray structure is available; building a three-dimensional model for the test NR polypeptide, examining the three-dimensional model of the test NR polypeptide sequence for difference |
| 08/18/2005 | US20050181038 Novel method of stabilizing diagnostic and therapeutic compounds in a cationic carrier system |
| 08/18/2005 | US20050181025 Physiologically acceptable salt of hyaluronic acid, iodine and potassium iodine; disinfects wound and reduces infection, removes secretions thereby reducing maceration, maintains wound hydration, and enhances granulation and epithelial cell formation of wounded tissue |
| 08/18/2005 | US20050180973 TREM-1 splice variant for use in modifying immune responses |
| 08/18/2005 | US20050180931 Contains an alkyl benzoate such as 3,7-dimethyloctyl benzoate (isodecyl benzoate); gives a refreshing sensation; sunblocks; superior long term emulsion stability |
| 08/18/2005 | CA2555328A1 Composition, comprising l-serine, l-isoleucine, folic acid and trace elements, for treating psoriasis |
| 08/18/2005 | CA2555296A1 Composition of labdane diterpenes extracted from andrographis paniculata, useful for the treatment of autoimmune diseases, and alzheimer disease by activation of ppr-gamma receptors |
| 08/18/2005 | CA2555262A1 1h-thieno[2,3-c]pyrazole derivatives useful as kinase inhibitors |
| 08/18/2005 | CA2554628A1 Methods of modulating cd200 and cd200r |
| 08/18/2005 | CA2554591A1 Photodynamic therapy for the treatment of acne |
| 08/17/2005 | EP1563845A1 Remedies for allergic diseases |
| 08/17/2005 | EP1563843A1 Botulinum toxins for treating various disorders and associated pain |
| 08/17/2005 | EP1563836A1 Drug for inhibiting production of matrix metalloprotease-9 |
| 08/17/2005 | EP1562967A2 Adipocyte complement related protein zacrp14 |
| 08/17/2005 | EP1562958A1 N-sulfonylaminothiazole |
| 08/17/2005 | EP1562933A2 Substituted amine derivatives and methods of use in the treatment of angiogenesis related disorders |
| 08/17/2005 | EP1562632A2 Inducible ligand for alpha1 beta1 integrin and uses |
| 08/17/2005 | EP1562621A1 Composition and method for treating inflammatory diseases using protease inhibitors |
| 08/17/2005 | EP1562585A1 Daily melatonin dosing units |
| 08/17/2005 | EP1562579A1 Therapeutic delivery of carbon monoxide |
| 08/17/2005 | EP1562547A1 Method of stimulating hair growth using benzopyrans |
| 08/17/2005 | EP1496889B1 Stabilized ascorbic acid derivatives |
| 08/17/2005 | EP1429617A4 Methods for sterilizing preparations of digestive enzymes |
| 08/17/2005 | EP1411978A4 Botulinum toxin in the treatment or prevention of acne |
| 08/17/2005 | EP1377558B1 [1,4]-diazepane-1-carboxylic acid derivatives, process for their preparation and their use as tachykinin antagonists |
| 08/17/2005 | EP1315496B1 The treatment of inflammatory disorders |
| 08/17/2005 | EP1289951B1 Growth hormone secretagogues |
| 08/17/2005 | EP1282639B1 Polyamide nucleic acid derivatives, agents and methods for producing the same |
| 08/17/2005 | EP1280757B1 New gamma selective retinoids |
| 08/17/2005 | EP1161240B1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 08/17/2005 | EP1144385B1 Benzoheterocycles and their use as mek inhibitors |
| 08/17/2005 | EP1039891B1 Treatment of scar tissue using lipoic acid |
| 08/17/2005 | EP1023445B1 Cadherin derived growth factor and the application thereof |
| 08/17/2005 | EP0732930B1 Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof |
| 08/17/2005 | CN1656114A Novel pancortin-pablo protein interactions and methods of use thereof |
| 08/17/2005 | CN1656099A 3-heteroaryl-3, 5-dihydro-4-oxo-4h-pyridazino[4, 5-b]indole-1-acetamide derivatives, preparation and use thereof in medicaments |
| 08/17/2005 | CN1656095A Spiro derivatives and adhesion molecule inhibitors comprising the same as the active ingredient |
| 08/17/2005 | CN1656094A 7-azaindoles as inhibitors of c-Jun N-terminal kinases for the treatment of neurodegenerative disorders |
| 08/17/2005 | CN1656093A 3-substituted quinuclidines and their use |
| 08/17/2005 | CN1656089A Phenyl-thiophene type vitamin D receptor modulators |
| 08/17/2005 | CN1656088A Substituted chroman derivatives having cytochrome P450RAI inhibitory activity |
| 08/17/2005 | CN1656085A Carboxylic acid compounds and drugs containing the compounds as the active ingredient |
| 08/17/2005 | CN1656082A Protein kinase inhibitors |
| 08/17/2005 | CN1656081A 4-anilino quinazoline derivatives as antiproliferative agents |
| 08/17/2005 | CN1656073A Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases |
| 08/17/2005 | CN1656072A Phenyl heterocyclyl ether derivatives as serotonin re-uptake inhibitors |
| 08/17/2005 | CN1656069A 1-(aminoalkyl)-3-sulfonylindole and-indazole derivatives as 5-hydroxytryptamine-6 ligands |
| 08/17/2005 | CN1656065A Ligand as the RAR receptor inhibitor |
| 08/17/2005 | CN1655823A Topically applicable pharmaceutical preparation |
| 08/17/2005 | CN1655819A Pharmaceutical composition comprising a renin inhibitor, a calcium channel blocker and a diuretic |
| 08/17/2005 | CN1655814A Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 08/17/2005 | CN1655813A Parakeratosis inhibitor, pore-shrinking agent and skin preparation for external use |
| 08/17/2005 | CN1655811A 组合物及其治疗用途 The composition and therapeutic use |
| 08/17/2005 | CN1655809A Compositions and methods for treating and preventing necrosis |
| 08/17/2005 | CN1655800A Chloasma amelioration composition and dullness amelioration composition |
| 08/17/2005 | CN1655788A 1H-imidazo[4, 5-c]quinoline derivatives in the treatment of protein kinase dependent diseases |
| 08/17/2005 | CN1655786A Combination of a DPP IV inhibitor and a cardiovascular compound |